The Art of Diabetes Education: Strategies for Effective Patient Counseling on World Diabetes Day
“Globally, around 422 million people have diabetes, and 1.5 million deaths are directly attributed to diabetes every year.” Dr...
Tirzepatide, A recently approved drug targets two receptors to fight diabetes
In May, the US FDA approved Mounjaro (tirzepatide) for adults with Type 2 diabetes who are also using diet...
Recent review: A Peep in the world of Diabetes.
The medical literature on diabetes research, both in terms of development and management, is intriguing.There was a recent study...
Ion channel may link hyperglycemia to clotting risk in diabetes
Diabetes comes along with a higher risk for thrombosis. Research published in January 2022 points to a potential mechanism...
Management of long-term health in women with PCOS
New research shows the global prevalence of obesity and its contribution to the pathogenesis of polycystic ovary syndrome (PCOS)....
SGLT2 inhibitors and GLP1 agonists in Diabetes Type 2
Over the last few years, there have been significant breakthroughs in the management of Type 2 diabetes (T2D). Sodium–glucose...
Dapagliflozin approved for use in chronic kidney disease
The SGLT2 inhibitors, or gliflozins, have been rising stars in the fields of endocrinology and cardiology for their ability...
New Findings Provide Hope for Neuroprotection in Glaucoma
Scientists at Karolinska Institutet and St. Erik Eye Hospital find new ways to treat glaucoma, a common neurodegenerative disease. A...
GLP-1 receptor agonists and/or DPP4 inhibitors: Diabetes drugs may lower the risk of Parkinson’s disease
Parkinson’s disease, the most common neurodegenerative movement disorder has growing prevalence with the age. Due to increasing life expectancy...
A Blood Glucose-Lowering Drug with the Potential to Protect Cardiovascular Health
Patients with diabetes are at risk of cardiovascular disease. Heart failure, myocardial infarction, and stroke are all more common...